Flood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia

被引:0
|
作者
Cerhan, JR
Wallace, RB
Dick, F
Kemp, J
Parker, AS
Zheng, W
Sellers, TA
Folsom, AR
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[4] Univ S Carolina, Sch Publ Hlth, S Carolina Canc Ctr, Columbia, SC 29203 USA
[5] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic blood transfusion has been suggested as a risk factor for non-Hodgkin's lymphoma (NHL), possibly specific to certain NHL subtypes, or chronic lymphocytic leukemia (CLL). Self-reported transfusion history and risk of NHL subtypes and CLL were examined in a cohort of 37,934 older Iowa women, using data from a questionnaire mailed in 1986. Through 1997, 229 cases of NHL and 57 cases of CLL in the cohort were identified through linkage to the Iowa Surveillance, Epidemiology and End Results Cancer Registry. Women who reported ever receiving a blood transfusion were at increased risk for all NHLs [age adjusted relative risk (RR), 1.6; 95% confidence interval (CI), 1.2-2.1). On the basis of the Working Formulation classification, blood transfusion was positively associated with low-grade NHL (RR, 2.7; 95% CI, 1.7-4.5) but not with intermediate-grade NHL (RR, 1.1; 95% CI, 0.7-1.6); there were only 8 cases of high-grade NHL. Blood transfusion was positively associated with follicular (RR, 2.8; 95% CI, 1.6-5.1) and small lymphocytic (RR, 3.4; 95% CI, 1.5-7.9) NHL subtypes but not with diffuse NHL (RR, 1.0; 95% CI, 0.7-1.5). There was also a positive association with CLL (RR, 1.7; 95% CI, 1.0-3.0). Finally, transfusion was associated with nodal (RR, 1.8; 95% CI, 1.3-2.5) but not extranodal (RR, 1.2; 95% CI, 0.7-2.1) NHL. Further adjustment for marital status, farm residence, diabetes, alcohol use, smoking, and red meat and fruit consumption did not alter these associations. In conclusion, prior blood transfusion was associated with NHL and CLL, and the strongest associations were seen for low-grade NHL, particularly follicular and small lymphocytic NHL.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [41] Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia: Spanish Registry
    Sanchez-Gonzalez, B.
    Penalver, F.
    Guillen, H.
    Calleja, M.
    de Ona, R.
    Canovas, A.
    Gironella, M.
    Arranz, R.
    Loscercales, J.
    de la Fuente, I.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [42] Increased frequency of small fiber neuropathy in chronic lymphocytic leukemia and non-Hodgkin lymphoma patients
    Pamuk, Gulsum Emel
    Maden, Muhammet
    Tekatas, Aslan
    Pamuk, Omer Nuri
    LEUKEMIA & LYMPHOMA, 2015, 56 : 119 - 120
  • [43] Multiple myeloma, chronic lymphocytic leukemia, non-Hodgkin Lymphoma: Evidence for overlapping genetic etiologies
    Camp, N. J.
    Werner, T. L.
    Cannon-Albright, L. A.
    GENETIC EPIDEMIOLOGY, 2007, 31 (06) : 607 - 607
  • [44] Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non-Hodgkin lymphoma
    Tam, Constantine S.
    Wolf, Max
    Prince, H. Miles
    Januszewicz, E. Henry
    Westerman, David
    Lin, Katherine I.
    Carney, Dennis
    Seymour, John F.
    CANCER, 2006, 106 (11) : 2412 - 2420
  • [45] Subcutaneous rituximab with recombinant human hyaluronidase in the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia
    Hill, Samuel Luke
    Davies, Andrew
    FUTURE ONCOLOGY, 2018, 14 (17) : 1691 - 1699
  • [46] Mapping of the IRF8 Gene Identifies a 3′UTR Variant Associated with Risk of Chronic Lymphocytic Leukemia but not Other Common Non-Hodgkin Lymphoma Subtypes
    Slager, Susan L.
    Achenbach, Sara J.
    Asmann, Yan W.
    Camp, Nicola J.
    Rabe, Kari G.
    Goldin, Lynn R.
    Call, Timothy G.
    Shanafelt, Tait D.
    Kay, Neil E.
    Cunningham, Julie M.
    Wang, Alice H.
    Weinberg, J. Brice
    Norman, Aaron D.
    Link, Brian K.
    Leis, Jose F.
    Vachon, Celine M.
    Lanasa, Mark C.
    Caporaso, Neil E.
    Novak, Anne J.
    Cerhan, James R.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2013, 22 (03) : 461 - 466
  • [47] The composite lymphoma: chronic lymphocytic leukemia - classic Hodgkin's lymphoma
    Badea, M.
    Dobrea, Camelia
    Badea, Daniela
    Genunche-Dumitrescu, Amelia
    Mitrut, P.
    Duta, Doriana
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (02): : 353 - 358
  • [48] RituximabA Review of its Use in Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia
    Risto S. Cvetković
    Caroline M. Perry
    Drugs, 2006, 66 : 791 - 820
  • [49] Rituximab - A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia
    Cvetkovic, Risto S.
    Perry, Caroline M.
    DRUGS, 2006, 66 (06) : 791 - 820
  • [50] Rituximab - A review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia
    Plosker, GL
    Figgitt, DP
    DRUGS, 2003, 63 (08) : 803 - 843